Ellis–van Creveld syndrome

From WikiMD's WELLNESSPEDIA

Rare genetic disorder

Ellis–van Creveld syndrome



Synonyms Chondroectodermal dysplasia



Symptoms Short stature, polydactyly, congenital heart defects, dental abnormalities


Usual onset Birth
Duration Lifelong


Causes Genetic mutation in EVC or EVC2 genes


Diagnosis Clinical evaluation, genetic testing
Differential diagnosis Achondroplasia, Jeune syndrome


Treatment Symptomatic management, surgical interventions


Prognosis Variable, depending on severity of symptoms
Frequency Rare



Ellis–van Creveld syndrome (EVC), also known as chondroectodermal dysplasia, is a rare genetic disorder that affects the development of the bones, teeth, and other parts of the body. It is named after the physicians Richard W. B. Ellis and Simon van Creveld, who first described the condition in 1940.

Signs and symptoms[edit]

Individuals with Ellis–van Creveld syndrome typically present with:

Genetics[edit]

Ellis–van Creveld syndrome is inherited in an autosomal recessive manner. It is caused by mutations in the EVC or EVC2 genes, which are located on chromosome 4. These genes are involved in the Hedgehog signaling pathway, which is crucial for normal skeletal development.

Diagnosis[edit]

Diagnosis of Ellis–van Creveld syndrome is based on clinical evaluation and confirmed by genetic testing. Prenatal diagnosis is possible through amniocentesis or chorionic villus sampling if there is a known family history of the disorder.

Treatment[edit]

There is no cure for Ellis–van Creveld syndrome. Treatment focuses on managing symptoms and may include:

  • Surgical correction of congenital heart defects
  • Orthopedic surgery for polydactyly and other skeletal abnormalities
  • Dental care for managing dental abnormalities
  • Regular monitoring and supportive care

Prognosis[edit]

The prognosis for individuals with Ellis–van Creveld syndrome varies depending on the severity of symptoms. With appropriate medical care, many individuals can lead relatively normal lives, although they may face challenges related to their physical abnormalities.

Related pages[edit]

References[edit]



This genetic disorder related article is a stub. You can help WikiMD by expanding it.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.